Search PubMedSearch

PubMed · 9508882

Expansion.

Abstract

Expansion of dental arches has been in practice for a long time and will be around for years to come. Correct diagnosis along with familiarity of the appliance to be used will enhance the results of orthodontic treatment. The NPE incorporates many of the functions that exist in several different appliances. It can be used for maxillary corrections, crossbites, distal rotation and expansion of molars, molar stabilization, auxiliary placement for habit correction, intrusion of molars, three-way Saggital with utility arch, as an aid in Class II correction retainer, etc. It can be used in primary dentition, mixed dentition, adult dentition, cleft palate patients, surgery cases, Class III cases, and TMJ cases. Most patients can benefit from the use of this one appliance. I will continue to use the NPE and possibly discover more uses for it as I work with it.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

D C Pulsipher. 1996. Expansion.. https://pubmed.ncbi.nlm.nih.gov/9508882/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Assay of plasma samples representing different HIV-1 genetic subtypes: an evaluation of new versions of the amplicor HIV-1 monitor assay.

Quantification of plasma HIV-1 RNA levels has rapidly become the main tool for monitoring disease progression and treatment. However, some first-generation assays do not accurately quantify all HIV-1 subtypes. This study compares the first-generation and two newer prototype Amplicor HIV-1 Monitor assays (Roche Diagnostic Systems) in terms of their performance in quantifying HIV-1 RNA in stored plasma samples from 101 individuals infected with various genetic subtypes of HIV-1 (28 subtype A, 18 B, 26 C, 20 D, 2 E, 3 G, 2 H, and 2 J). The HIV-1 subtype had previously been determined by direct sequencing of the V3 domain of the env gene. The results from the three assays agreed for subtypes B and C, as well as for most subtype D samples. In contrast, the first-generation assay reported significantly lower plasma HIV-1 RNA levels than did the two newer versions of the assay for most subtype A, E, G, and H samples. There were no differences in mean plasma HIV-1 RNA levels between individuals infected with subtypes A, B, C, and D if the results from the two newer test versions were used, and if an adjustment was made between subtypes for differences in CD4 count. Thus, this study confirms that the first-generation assay does not accurately quantify HIV-1 RNA levels in many individuals infected with subtype A, E, G, and H. These problems appeared to have been greatly reduced in the two new prototype versions.

Evaluation Studies as Topic